Diets low in fibre and omega-3 fatty acids linked to poorer response to immunotherapy.
Researchers and clinicians from Melanoma Institute Australia have played a leading role at the recent ESMO Congress in Paris.
Prof Long has been named No 1 Melanoma Expert in worldwide rankings just released by expertscape, based on articles published 2012-2022.
New clinical tool developed by Melanoma Institute Australia hailed a breakthrough in personalising treatment for all cancer patients.
An unprecedented number of breakthroughs to be presented by MIA researchers at world's leading clinical oncology conference.
Immunotherapy after surgery proven effective in reducing disease spread in high risk early stage patients.
Australian researchers and patients were critical to trialling this breakthrough new treatment for advanced melanoma patients.
In what is being hailed as one of the biggest breakthroughs in melanoma treatment since the advent of immunotherapy, a new study has revealed that drug treatment before surgery is effective in preventing deadly spread of the disease.
MIA has joined Sydney Health Partners, with a shared focus on more rapidly translating research evidence into patient benefit.
A promising young MIA researcher is conferred with University of Sydney PhD.